Hi wowhappens28 I see that gap down. I nothing a
Post# of 63699
(Total Views: 242)
Posted On: 08/23/2019 12:14:07 PM
Re: wowhappens28 #60314
Hi wowhappens28
I see that gap down.
I nothing about that company.
SEEL
9:01 am ET 8/23/19
*Seelos Therapeutics Prices 4.475M Share Registered Direct Offering At $1.50/Share
Benzinga
Seelos Therapeutics Announces Pricing of $6.7 Million Registered Direct OfferingGlobeNewswire | 08/23/2019
Healthcare - Top 5 Gainers / LosersSeeking Alpha | 08/23/2019
Seelos prices stock offering at $1.50; shares down 20% premarketSeeking Alpha | 08/23/2019
FL, VMW among premarket losersSeeking Alpha | 08/23/2019
Seelos Therapeutics Announces FDA Acceptance of IND Application for SLS-005 for Mucopolysaccharidosis Type III (Sanfilippo Syndrome)GlobeNewswire | 08/22/2019
Seelos on go to launch pivotal study of trehalose in Sanfilippo; shares up 7%Seeking Alpha | 08/22/2019
GME, JWM among premarket gainersSeeking Alpha | 08/22/2019
9:19 am ET
*Seelos Therapeutics shares are trading higher after the company announced FDA acceptance of IND application for SLS-005 for Mucopolysaccharidosis Type III Sanfilippo Syndrome.
Benzinga
I see that gap down.
I nothing about that company.
SEEL
9:01 am ET 8/23/19
*Seelos Therapeutics Prices 4.475M Share Registered Direct Offering At $1.50/Share
Benzinga
Seelos Therapeutics Announces Pricing of $6.7 Million Registered Direct OfferingGlobeNewswire | 08/23/2019
Healthcare - Top 5 Gainers / LosersSeeking Alpha | 08/23/2019
Seelos prices stock offering at $1.50; shares down 20% premarketSeeking Alpha | 08/23/2019
FL, VMW among premarket losersSeeking Alpha | 08/23/2019
Seelos Therapeutics Announces FDA Acceptance of IND Application for SLS-005 for Mucopolysaccharidosis Type III (Sanfilippo Syndrome)GlobeNewswire | 08/22/2019
Seelos on go to launch pivotal study of trehalose in Sanfilippo; shares up 7%Seeking Alpha | 08/22/2019
GME, JWM among premarket gainersSeeking Alpha | 08/22/2019
9:19 am ET
*Seelos Therapeutics shares are trading higher after the company announced FDA acceptance of IND application for SLS-005 for Mucopolysaccharidosis Type III Sanfilippo Syndrome.
Benzinga
(0)
(0)Scroll down for more posts ▼